Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin’s lymphoma
Open Access
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier
- Vol. 9 (11) , 1213-1217
- https://doi.org/10.1023/a:1008446430765
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation reportBritish Journal of Cancer, 1996
- Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.Journal of Clinical Oncology, 1994
- EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1993
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Chronic Administration of Etoposide in the Treatment of Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1993
- Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1991
- Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.Journal of Clinical Oncology, 1991
- The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.Journal of Clinical Oncology, 1990
- VP-16-213 in the treatment of stage III and IV diffuse large cell lymphomaCancer, 1985
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976